drugset / Trial / NCT01300533
A Study of BIND-014 Given to Patients With Advanced or Metastatic Cancer
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The goal of this Phase 1 clinical research study is to find the highest safe dose of BIND-014 that can be given in the treatment of patients with advanced or metastatic cancer.
Timeline
- Start
- 2011-01
- Primary completion
- 2013-09
- Completion
- 2016-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Docetaxel | Small molecule | — | Intravenous |